- Investing Ideas
- Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Indian Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
1 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
Abbott India
Market Cap: ₹590.4b
Operates as a pharmaceutical company in India.
500488
₹27,784.15
7D
-0.8%
1Y
-17.5%
GlaxoSmithKline Pharmaceuticals
Market Cap: ₹449.5b
Manufactures, distributes, and trades in pharmaceuticals in India and internationally.
500660
₹2,653.45
7D
5.6%
1Y
-9.6%
Sanofi India
Market Cap: ₹76.5b
Manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally.
500674
₹3,320.20
7D
-2.0%
1Y
-40.2%
Hester Biosciences
Market Cap: ₹21.1b
Manufactures and trades in veterinary vaccines and health products in India and internationally.
New
524669
₹2,482.05
7D
5.0%
1Y
13.7%